Frail Elderly SyndromeNCT03688932
Effects of WBV Associated With IMT on Functionality
A study testing WBV + IMT in people with Frail Elderly Syndrome, run by Universidade Federal de Pernambuco at 1 site in Brazil.
Trial summary
The pre-frail elderly are a population more vulnerable to diminished functionality and future disabilities. Thus, interventions focused on the prevention of sarcopenia are indicated to prevent dysfunction in this population. Read more about this study
- Who is it for?
- Ages 60 to 80 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Frail Elderly Syndrome
- What is being tested?
- WBV + IMT
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 42 participants
- Where
- 1 siteBrazil
- Study dates
- 1 Oct 2018to 30 Jul 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 80 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- To able to walk without assistance
- Good understanding to carry out the proposed tests, evaluated through the Mini Mental State Examination (MMSE).
Who cannot join
- Contraindication or difficulty to perform evaluation procedures
- Users of medications that interfere with the cardiovascular and / or muscular system
- Smokers
- Neuromuscular or degenerative diseases
- Pulmonary comorbidities
- Heart diseases and labyrinthitis
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Whole Body Vibration Associated With the Inspiratory Muscle Training Program on Functional Capacity, Balance and Muscle Metabolism
The pre-frail elderly are a population more vulnerable to diminished functionality and future disabilities. Thus, interventions focused on the prevention of sarcopenia are indicated to prevent dysfunction in this population. This study aims to evaluate the effects of whole body vibration training associated with inspiratory muscle training on functional outcomes, balance and muscle metabolism in pre-frail elderly women.
- Conditions
- Frail Elderly Syndrome
- Being tested
- WBV + IMT, WBV + IMTsham, WBVsham + IMTsham
- Keywords
- aging, functional capacity, muscle metabolism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
WBV + IMTOther
The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training will be performed through a device that provides inspiratory resistance.
WBV + IMTshamOther
The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training sham will be performed through a device without inspiratory resistance.
WBVsham + IMTshamOther
Whole body vibration training will be performed through a vibrating platform coupled to a device that generates non-therapeutic low frequency vibration. The simulation of inspiratory muscle training will be performed through a device with no inspiratory resistance.
| Study group | Role | What they receive |
|---|---|---|
| WBV + IMT | Experimental | Whole body vibration training associated with respiratory muscle training (WBV + IMT) Receives: Other: WBV + IMT |
| WBV + IMTsham | Active comparator | Whole body vibration training associated with respiratory muscle training sham (WBV + IMTsham) Receives: Other: WBV + IMTsham |
| WBVsham + IMTsham | Sham comparator | Whole body vibration training sham associated with respiratory muscle training sham (WBVsham + IMTsham) Receives: Other: WBVsham + IMTsham |
What is being measured
The primary outcome is the main question the study is designed to answer.
Walking Distance
The walking distance will be assessed through the six-minute walk test.
Measured: Change from Baseline walking distance at 3 months
Secondary outcomes (4)
Balance
Static balance and dynamic balance will be evaluated through the Tinetti test
Measured: Change from Baseline balance at 3 months
Functionality
It will be evaluated through the Timed Up and Go (TUG) test.
Measured: Change from Baseline functionality at 3 months
Hand grip strength
The strength of the dominant hand will be evaluated by dynamometry.
Measured: Change from Baseline hand grip strength at 3 months
Muscle Metabolism
It will be assessed through the blood lactate and glucose rate after moderate physical activity.
Measured: Change from Baseline muscle metabolism at 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2018
- Study start1 Oct 2018
- Primary completion30 May 2019
- Study completion30 Jul 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Frail Elderly SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidade Federal de Pernambuco
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Helga Cecília Muniz de Souza, Universidade Federal de Pernambuco
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03688932
- Sponsor's protocol ID
- WBV on Functionality
- Status last verified
- Sep 2019
- First submitted
- 25 Sep 2018
- Last updated
- 25 Sep 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Whole Body Vibration Associated With the Inspiratory Muscle Training Program on Functional Capacity, Balance and Muscle Metabolism
- ClinicalTrials.gov ID
- NCT03688932
- Acronym / sponsor ID
- WBV on Functionality
- Conditions
- Frail Elderly Syndrome
- Keywords
- aging, functional capacity, muscle metabolism
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Universidade Federal de PernambucoUniversity, hospital or other
- Study start
- 1 Oct 2018 (actual)
- Primary completion
- 30 May 2019 (actual)
- Study completion
- 30 Jul 2019 (actual)
- First posted
- 28 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The pre-frail elderly are a population more vulnerable to diminished functionality and future disabilities. Thus, interventions focused on the prevention of sarcopenia are indicated to prevent dysfunction in this population. This study aims to evaluate the effects of whole body vibration training associated with inspiratory muscle training on functional outcomes, balance and muscle metabolism in pre-frail elderly women.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| WBV + IMT | Experimental | Other: WBV + IMTWhole body vibration training associated with respiratory muscle training (WBV + IMT) |
| WBV + IMTsham | Active comparator | Other: WBV + IMTshamWhole body vibration training associated with respiratory muscle training sham (WBV + IMTsham) |
| WBVsham + IMTsham | Sham comparator | Other: WBVsham + IMTshamWhole body vibration training sham associated with respiratory muscle training sham (WBVsham + IMTsham) |
Who may qualify
- Ages
- 60 to 80 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- To able to walk without assistance
- Good understanding to carry out the proposed tests, evaluated through the Mini Mental State Examination (MMSE).
Key exclusion criteria (6 listed)
- Contraindication or difficulty to perform evaluation procedures
- Users of medications that interfere with the cardiovascular and / or muscular system
- Smokers
- Neuromuscular or degenerative diseases
- Pulmonary comorbidities
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| WBV + IMTThe whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training will be performed through a device that provides inspiratory resistance. | Other | WBV + IMT |
| WBV + IMTshamThe whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz. The amplitude used will be 02 to 04 mm.The inspiratory muscle training sham will be performed through a device without inspiratory resistance. | Other | WBV + IMTsham |
| WBVsham + IMTshamWhole body vibration training will be performed through a vibrating platform coupled to a device that generates non-therapeutic low frequency vibration. The simulation of inspiratory muscle training will be performed through a device with no inspiratory resistance. | Other | WBVsham + IMTsham |
Primary outcome
Walking Distance
Time frame: Change from Baseline walking distance at 3 months
The walking distance will be assessed through the six-minute walk test.
4 secondary outcomes
Balance
Time frame: Change from Baseline balance at 3 months
Functionality
Time frame: Change from Baseline functionality at 3 months
Hand grip strength
Time frame: Change from Baseline hand grip strength at 3 months
Muscle Metabolism
Time frame: Change from Baseline muscle metabolism at 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2019.
Related trials for Frail Elderly Syndrome
Active, not recruiting
Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program
Frail Elderly Syndrome
Recruiting
Feasibility and Effects of Inspiratory Muscle Training Combined With Blood Flow Restriction for Frail Older Adults
Frailty Syndrome, Older Adults
Recruiting
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Diabetes Type 2, Frail Elderly Syndrome
Not yet recruiting
Comparıson of the Effıcacy of Conventıonal Exercıse and Pılates ın Pre-fraıl and Fraıl Older Adults
Frailty Syndrome, Prefrail Elderly
Recruiting
The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With T2DM
Type2diabetes, Frail Elderly Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing WBV + IMT in people with Frail Elderly Syndrome, run by Universidade Federal de Pernambuco at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Walking Distance (time frame: Change from Baseline walking distance at 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2019.